This is a Validated Antibody Database (VAD) review about Rhesus mon.. CCR6, based on 17 published articles (read how Labome selects the articles), using CCR6 antibody in all methods. It is aimed to help Labome visitors find the most suited CCR6 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCR6 synonym: C-C chemokine receptor type 6; CC chemokine receptor 6

BioLegend
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (fig 3e). Front Immunol (2018) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 2d
BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples (fig 2d). Ann Rheum Dis (2018) ncbi
mouse monoclonal (G034E3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7
  • flow cytometry; human; loading ...; fig 3a
BioLegend CCR6 antibody (BioLegend, G034E3) was used in immunohistochemistry - paraffin section on human samples (fig 7) and in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig s1
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (fig s1). Oncoimmunology (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CCR6 antibody (Biolegend, 353412) was used in flow cytometry on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize gammadelta T cell subsets from healthy humans, BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples (fig 4a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 3a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples (fig 3a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; Rhesus monkey; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CCR6 antibody (BioLegend, 353410) was used in flow cytometry on Rhesus monkey samples . Nat Med (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 5a
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend CCR6 antibody (BioLegend, 353418) was used in flow cytometry on human samples (fig 5a). Haematologica (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; fig 1
BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CCR6 antibody (biolegend, G034E3) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human; fig 2
BioLegend CCR6 antibody (BioLegend, G034E3) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (G034E3)
  • flow cytometry; human
BioLegend CCR6 antibody (Biolegend, G034E3) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
Articles Reviewed
  1. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed publisher
  2. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  3. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed publisher
  4. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  5. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  6. Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed publisher
  7. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  8. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  9. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  10. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  11. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  12. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  13. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  14. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  15. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  16. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  17. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher